Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 629

1.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285
2.

Pharmacology of cannabinoids.

Grotenhermen F.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):14-23. Review.

PMID:
15159677
3.

Cannabinoid receptors and their ligands.

Pertwee RG, Ross RA.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21. Review.

PMID:
12052030
4.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
5.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

6.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
7.

Cannabinoids and the gut: new developments and emerging concepts.

Izzo AA, Sharkey KA.

Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1. Review.

PMID:
20117132
8.

CB receptor ligands from plants.

Woelkart K, Salo-Ahen OM, Bauer R.

Curr Top Med Chem. 2008;8(3):173-86. Review.

PMID:
18289087
9.
10.

Cannabinoid receptors and pain.

Pertwee RG.

Prog Neurobiol. 2001 Apr;63(5):569-611. Review.

PMID:
11164622
11.

Cannabinoids for gastrointestinal diseases: potential therapeutic applications.

Di Carlo G, Izzo AA.

Expert Opin Investig Drugs. 2003 Jan;12(1):39-49. Review.

PMID:
12517253
12.

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

Pertwee RG.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. Review.

PMID:
10575283
13.

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.

Rice AS, Farquhar-Smith WP, Nagy I.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):243-56. Review.

PMID:
12052040
14.

Behavioral effects of cannabinoid agents in animals.

Chaperon F, Thiébot MH.

Crit Rev Neurobiol. 1999;13(3):243-81. Review.

PMID:
10803637
15.

Cannabis and the brain.

Iversen L.

Brain. 2003 Jun;126(Pt 6):1252-70. Review.

16.

Cannabinoid modulation of peripheral autonomic and sensory neurotransmission.

Ralevic V.

Eur J Pharmacol. 2003 Jul 4;472(1-2):1-21. Review.

PMID:
12860468
17.

Cannabinoid system as a potential target for drug development in the treatment of cardiovascular disease.

Mendizábal VE, Adler-Graschinsky E.

Curr Vasc Pharmacol. 2003 Oct;1(3):301-13. Review.

PMID:
15320476
18.

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA.

Mol Pharmacol. 2008 Feb;73(2):441-50. Epub 2007 Oct 26.

19.

Cannabinoid receptor systems: therapeutic targets for tumour intervention.

Jones S, Howl J.

Expert Opin Ther Targets. 2003 Dec;7(6):749-58. Review.

PMID:
14640910
20.

Pharmacokinetics and pharmacodynamics of cannabinoids.

Grotenhermen F.

Clin Pharmacokinet. 2003;42(4):327-60. Review.

PMID:
12648025
Items per page

Supplemental Content

Write to the Help Desk